The Complete Consumer Guide to Naproxen Sodium: Uses, Dosage, Warnings, and Latest Innovations
Naproxen sodium is an arylacetic acid derivative belonging to the broader family of nonsteroidal anti-inflammatory drugs (NSAIDs). When bodily tissues experience trauma, micro-tears, or immune-mediated wear, damaged cells release arachidonic acid. Two primary cyclooxygenase enzymes, COX-1 and COX-2, convert this acid into prostaglandins, hormone-like lipids that dilate blood vessels, recruit inflammatory cells, and sensitize peripheral nerve endings to pain signals.
By competitively inhibiting both COX-1 and COX-2 enzymes, naproxen sodium reduces the synthesis of these inflammatory mediators. The addition of the sodium salt component accelerates gastrointestinal absorption. Patients reach peak plasma concentrations within 1 to 2 hours of ingestion, noticeably faster than standard base naproxen formulations. In European and Latin American markets, this chemistry often appears under brand names like the Antalgin formulation, prescribed widely for rapid-onset orthopedic distress.
Because naproxen binds heavily to plasma albumin (greater than 99%), it clears the body slowly through hepatic metabolism and renal excretion. This metabolic clearance gives the drug an elimination half-life ranging between 12 and 17 hours. The clinical payoff is substantial: patients maintain consistent symptom suppression without the erratic peaks and troughs common to four-hour pain relievers.
